US3724274010 - Common Stock
GENOCEA BIOSCIENCES INC
NASDAQ:GNCA (6/2/2022, 7:17:15 PM)
After market: 0.055 +0 (+7.84%)0.051
-0.01 (-15%)
Genocea Biosciences, Inc. engages in the development and commercialization of cancer vaccines. The company is headquartered in Cambridge, Massachusetts and currently employs 74 full-time employees. The company went IPO on 2014-02-05. The firm is focused on discovering and developing cancer immunotherapies using its Antigen Lead Acquisition System (ATLAS) platform. The ATLAS platform can profile each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by sequencing of that patient's tumor. Its product candidates include GEN-011 and GEN-009. GEN-011 is an investigational solid tumor cell therapy candidate, which consists of CD4+ and CD8+ neoantigen-targeted peripheral T cells (NPTs) which are specific for up to 30 antigens, designed to limit tumor escape. GEN-011 consists of T cells extracted from the patient’s peripheral blood and specific for ATLAS-prioritized neoantigens. GEN-009 is a neoantigen vaccine candidate delivering adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The firm is evaluating its Phase I/IIa of GEN-009.
GENOCEA BIOSCIENCES INC
100 Acorn Park Dr
Cambridge MASSACHUSETTS 02140
P: 16178768191.0
CEO: William Clark
Employees: 74
Website: http://www.genocea.com/
Welcome back and get ready because we're starting off the week with a breakdown of the biggest pre-market stock movers for Tuesday!
Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday!
Happiness Development (HAPP) stock is charging higher on Wednesday after the Chinese nutrition company announced plans to develop EVs.
Genocea Biosciences (GNCA) stock is on the move Wednesday after the bioscience company revealed its shutting down and delisting shares.
Here you can normally see the latest stock twits on GNCA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: